Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study

by Mohummad A. Rahman, Jorunn Brekke, Victoria Arnesen, Marianne H. Hannisdal, Andrea G. Navarro, Andreas Waha, Lars Herfindal, Cecilie B. Rygh, Eirik Bratland, Petter Brandal, Judit Haasz, Leif Oltedal, Hrvoje Miletic, Arvid Lundervold, Stein A. Lie, Dorota Goplen, Martha Chekenya
Published 2020-09-01